Researchers have found in a new research that HbA1c shows a strong association with the severity of diabetic peripheral ...
The FDA assigned INO-3107 a Prescription Drug User Fee Act (PDUFA) review goal date of October 30, 2026, which is the date by which it intends to take action on the application. The FDA has indicated ...
Plymouth Meeting, Pennsylvania Tuesday, December 30, 2025, 15:00 Hrs [IST] ...
Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Comprehensive Analysis Examines Liposomal NMN Delivery, Dosage Research Context, Third-Party Verification Standards, and What ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback